LIFEVANTAGE CORP Form 8-A12B: Registration of a class of securities on an exchange
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-08-31: Form 8-A12B; Description 8-A12B; Document lfvn-8xarightsplan.htm.
- 2018-03-13: Form 8-A12B/A; Description 8-A12B/A; Document a8-aa.htm.
- 2012-09-11: Form 8-A12B; Description FORM 8-A; Document d407951d8a12b.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2023-08-31 | 8-A12B | 8-A12B | lfvn-8xarightsplan.htm | |
| 2018-03-13 | 8-A12B/A | 8-A12B/A | a8-aa.htm | |
| 2012-09-11 | 8-A12B | FORM 8-A | d407951d8a12b.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |